Acute Lymphoblastic Leukemia, Adult Clinical Trials

20 clinical trials for Acute Lymphoblastic Leukemia, Adult across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia — RECRUITING · NA
• Determining the Mechanisms of Loss of CAR T Cell Persistence — RECRUITING
• CAR T-cell Therapy in Patients With Renal Dysfunction — RECRUITING · PHASE2
• Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL — RECRUITING · NA
• Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL — RECRUITING · NA
• Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL — RECRUITING · PHASE2
• Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine — RECRUITING · PHASE1
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL — RECRUITING · PHASE2
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL — RECRUITING · PHASE2
• Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR — RECRUITING · PHASE1
• TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies — RECRUITING · PHASE1
• RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL — RECRUITING
• Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative — COMPLETED
• Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL — TERMINATED · PHASE2
• High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD — WITHDRAWN · PHASE1
• Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INO — OTHER
• Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab — WITHDRAWN · PHASE2
• International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia — TERMINATED · PHASE1
• Study in Adult Ph-positive ALL — OTHER · PHASE2
• Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia — OTHER · PHASE2

Refine this search